Mice deficient for NLRP3 are protected from diet-induced insulin resistance due to failure to form the inflammasome complex; similarly, therapeutic intervention for weight loss in obesity and T2D reduces expression of NLRP3 and its target cytokines [32]. This evidence concerns the gene NLRP3 and obesity due to melanocortin 4 receptor deficiency.